Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Reitsma

Showing results (161-170 of 275) with videos related to

Pageof 28
Sort By:
British Journal of Haematology|May 12, 1998
Severe coagulation factor V deficiency caused by a 4 bp deletion in the factor V geneJ F Guasch, S Cannegieter, P H Reitsma, et al.
Human Genetics|July 1, 1992
Refined regional assignment of the human tissue factor pathway inhibitor (TFPI) gene to chromosome band 2q32 by non-isotopic in situ hybridizationC P Van der Logt, P M Kluck, J Wiegant, et al.
Thrombosis and Haemostasis|November 1, 1994
Construction and characterization of thrombin-resistant variants of recombinant human protein SG T Chang, L Aaldering, T M Hackeng, et al.
Thrombosis and Haemostasis|June 1, 2002
Mutation screening for thrombophilia: two cases with factor V Cambridge without activated protein C resistanceA J ten Cate, Y T van de Hoek, P H Reitsma, et al.
Thrombosis and Haemostasis|April 26, 2000
Recurrent venous thrombosis and markers of inflammationB E van Aken, M den Heijer, G M Bos, et al.
Journal of Thrombosis and Haemostasis : JTH|December 23, 2004
Tissue factor haploinsufficiency during endotoxin induced coagulation and inflammation in miceS H H F Schoenmakers, H H Versteeg, A P Groot, et al.
Carcinogenesis|January 1, 1997
Rat ferritin-H: cDNA cloning, differential expression and localization during hepatocarcinogenesisC G Wu, M Groenink, A Bosma, et al.
Journal of Thrombosis and Haemostasis : JTH|August 3, 2006
Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population studyS M Boekholdt, M S Sandhu, N J Wareham, et al.
Lancet (London, England)|January 16, 1993
Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defectC F Allaart, S R Poort, F R Rosendaal, et al.
Blood|October 1, 1996
Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factorJ C Eikenboom, T Matsushita, P H Reitsma, et al.
Pageof 28

Showing results (161-170 of 275) with videos related to

Sort By:
Pageof 28
British Journal of Haematology|May 12, 1998
Severe coagulation factor V deficiency caused by a 4 bp deletion in the factor V geneJ F Guasch, S Cannegieter, P H Reitsma, et al.
Human Genetics|July 1, 1992
Refined regional assignment of the human tissue factor pathway inhibitor (TFPI) gene to chromosome band 2q32 by non-isotopic in situ hybridizationC P Van der Logt, P M Kluck, J Wiegant, et al.
Thrombosis and Haemostasis|November 1, 1994
Construction and characterization of thrombin-resistant variants of recombinant human protein SG T Chang, L Aaldering, T M Hackeng, et al.
Thrombosis and Haemostasis|June 1, 2002
Mutation screening for thrombophilia: two cases with factor V Cambridge without activated protein C resistanceA J ten Cate, Y T van de Hoek, P H Reitsma, et al.
Thrombosis and Haemostasis|April 26, 2000
Recurrent venous thrombosis and markers of inflammationB E van Aken, M den Heijer, G M Bos, et al.
Journal of Thrombosis and Haemostasis : JTH|December 23, 2004
Tissue factor haploinsufficiency during endotoxin induced coagulation and inflammation in miceS H H F Schoenmakers, H H Versteeg, A P Groot, et al.
Carcinogenesis|January 1, 1997
Rat ferritin-H: cDNA cloning, differential expression and localization during hepatocarcinogenesisC G Wu, M Groenink, A Bosma, et al.
Journal of Thrombosis and Haemostasis : JTH|August 3, 2006
Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population studyS M Boekholdt, M S Sandhu, N J Wareham, et al.
Lancet (London, England)|January 16, 1993
Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defectC F Allaart, S R Poort, F R Rosendaal, et al.
Blood|October 1, 1996
Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factorJ C Eikenboom, T Matsushita, P H Reitsma, et al.
Pageof 28